IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Results from the first multicenter, open-label, phase IIIb study investigating the combination of pertuzumab with subcutaneous trastuzumab and a taxane in patients with HER2-positive metastatic breast cancer (SAPPHIRE)

RepositoryUniversity of Queensland [UQ eSpace]
URL
Author(s)Woodward, Natasha; De Boer, Richard H.; Redfern, Andrew; White, Michelle; Young, Jennifer; Truman, Matt; Beith, Jane
Item typeArticle
DOIhttps://doi.org/10.1016/j.clbc.2019.02.008

Usage Date Range

Note: Daily statistics are only available for the last six weeks.

     

Country Reporting Period Total 2021-12-13 2021-12-14 2021-12-15 2021-12-16 2021-12-17 2021-12-18 2021-12-19 2021-12-20 2021-12-21 2021-12-22 2021-12-23 2021-12-24 2021-12-25 2021-12-26 2021-12-27 2021-12-28 2021-12-29 2021-12-30 2021-12-31
Overall totals 3 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1
United States 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1
Spain 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Jisc logo Cranfield logo CAVAL logo